Outlook Therapeutics (OTLK) Cash & Equivalents (2015 - 2026)
Outlook Therapeutics (OTLK) posted Cash & Equivalents of $11.24 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 26.3% from $8.9 million a year earlier and up 45.1% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Cash & Equivalents came in at $8.08 million, down 45.9% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -8.4% (FY2020 to FY2025).
- In prior fiscal years, Outlook Therapeutics' Cash & Equivalents was $14.93 million in FY2024 (-36.2%), $23.39 million in FY2023 (+34.5%), $17.4 million in FY2022 (+20.2%) and $14.48 million in FY2021 (+15.5%).
- The fiscal Q3 2026 figure stands as the highest quarterly Cash & Equivalents since fiscal Q4 2024.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with an average decline of 25.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q2 2022, with growth of 57.2%; the weakest was fiscal Q2 2025, with a decline of 84.0%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $7.75 million (Q2 2026), $8.68 million (Q1 2026) and $8.08 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Outlook Therapeutics | 80.68 Mn | 44.93 Mn | -8,265.00 | 11.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.24 Mn |
| Mar 31, 2026 | 7.75 Mn |
| Dec 31, 2025 | 8.68 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Mar 31, 2025 | 7.56 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 14.93 Mn |
| Jun 30, 2024 | 32.02 Mn |
| Mar 31, 2024 | 47.23 Mn |
| Dec 31, 2023 | 10.36 Mn |
| Sep 30, 2023 | 23.39 Mn |
| Jun 30, 2023 | 33.71 Mn |
| Mar 31, 2023 | 43.63 Mn |
| Dec 31, 2022 | 52.34 Mn |
| Sep 30, 2022 | 17.40 Mn |
| Jun 30, 2022 | 26.02 Mn |
| Mar 31, 2022 | 58.42 Mn |
| Dec 31, 2021 | 70.15 Mn |
| Sep 30, 2021 | 14.48 Mn |
API Access
Outlook Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();